Triethylamine trihydrofluoride | CAS:73602-61-6

We serve Triethylamine trihydrofluoride CAS:73602-61-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Triethylamine trihydrofluoride

Chemical Name:Triethylamine trihydrofluoride
CAS.NO:73602-61-6
Synonyms:Triethylamine trihydrofluoride;
Hydrogen fluoride triethylamine
Molecular Formula:C6H18F3N
Molecular Weight:161.21
 
Specification:
It is used in the preparation of epoxides for the preparation of o-difluoride and 3-fluorinated azetidinal; as a mild selective reagent, it is widely used in the fluorination of many compounds.
 
Density:0.989;     
Boiling point:70oC;
Flash point:190oC;  
Index of Refraction:1.3915;
 
Appearance:Colorless to light yellow transparent liquid
Assay :≥98.0%
Moisture:≤0.1%



Contact us for information like Triethylamine trihydrofluoride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Hydrogen fluoride triethylamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Triethylamine trihydrofluoride Use and application,Triethylamine trihydrofluoride technical grade,usp/ep/jp grade.


Related News: But several border points remain open, and many medical workers fear that Hong Kong’s well-regarded health care system will be overwhelmed.7-hydroxy-1H-quinolin-2-one manufacturer In a stringent xenograft model of disseminated lymphoblastic leukemia, FT819 demonstrated enhanced tumor clearance and control of leukemia as compared to primary CAR19 T cells.2-Fluoro-5-nitrobenzoic acid supplier It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance.2,4,5,6-Tetraaminopyrimidine sulfate vendor This is of vital important and underlies one of the most solid principles and regulations of modern pharmacy.U.S. drugmaker Gilead dominates the HIV market and it will keep up the pressure with fast-growing Biktarvy, which was approved early last year.